ℹ️
🇬🇧
Search
Search for people relevant for "Spasmolytics"
Spasmolytics
Person
Class
Person
Publication
Programmes
prof. PharmDr. Ing. Milan Lázníček CSc.
External academic staff at Faculty of Pharmacy in Hradec Králové
1 class
127 publications
Class
class
Methods of Nuclear Analysis
GB234 |
Faculty of Pharmacy in Hradec Králové
Publications
publication
Radiolabeling of the antibody IgG M75 for epitope of human carbonic anhydrase IX by Cu-61 and Cu-64 and its biological testing
2019 |
Faculty of Science, Faculty of Pharmacy in Hradec Králové
publication
The 50th anniversary of the Faculty of Pharmacy of the Charles University in Hradec Králové
2019 |
Faculty of Pharmacy in Hradec Králové
publication
In vitro evaluation of the monoclonal antibody Cu-64-IgG M75 against human carbonic anhydrase IX and its in vivo imaging
2018 |
Faculty of Science, Faculty of Pharmacy in Hradec Králové, First Faculty of Medicine
publication
Preparation and biodistribution of Fe-59-radiolabelled iron oxide nanoparticles
2017 |
Faculty of Pharmacy in Hradec Králové, Third Faculty of Medicine
publication
The involvement of selected membrane transport mechanisms in the cellular uptake of Lu-177-labeled bombesin, somatostatin and gastrin analogues
2015 |
Faculty of Pharmacy in Hradec Králové
publication
Mono(pyridine-N-oxide) DOTA analog and its G1/G4-PAMAM dendrimer conjugates labeled with 177Lu: Radiolabeling and biodistribution studies
2014 |
Faculty of Science, Faculty of Pharmacy in Hradec Králové
publication
The effect of chelator type on in vitro receptor binding and stability in Lu-177-labeled cetuximab and panitumumab
2014 |
Faculty of Pharmacy in Hradec Králové
publication
Electrospinning of diosmin from aqueous solutions for improved dissolution and oral absorption
2014 |
Faculty of Pharmacy in Hradec Králové
publication
Preclinical evaluation of gastrin derivatives labelled with In-111: Radiolabelling, affinity profile and pharmacokinetics in rats
2014 |
Faculty of Pharmacy in Hradec Králové
publication
Preclinical evaluation of radiolabelled nimotuzumab, a promising monoclonal antibody targeting the epidermal growth factor receptor
2013 |
Faculty of Pharmacy in Hradec Králové
Load more publications (117)
Loading network view...